Target Price | $81.80 |
Price | $38.19 |
Potential |
114.20%
register free of charge
|
Number of Estimates | 22 |
22 Analysts have issued a price target Legend Biotech Corp - ADR 2025 .
The average Legend Biotech Corp - ADR target price is $81.80.
This is
114.20%
register free of charge
$95.00
148.76%
register free of charge
$60.00
57.11%
register free of charge
|
|
A rating was issued by 26 analysts: 24 Analysts recommend Legend Biotech Corp - ADR to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Legend Biotech Corp - ADR stock has an average upside potential 2025 of
114.20%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 285.14 | 619.87 |
143.69% | 117.39% | |
EBITDA Margin | -147.92% | -42.76% |
60.63% | 71.09% | |
Net Margin | -189.15% | -26.36% |
57.07% | 86.06% |
23 Analysts have issued a sales forecast Legend Biotech Corp - ADR 2024 . The average Legend Biotech Corp - ADR sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Legend Biotech Corp - ADR EBITDA forecast 2024. The average Legend Biotech Corp - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Legend Biotech Corp - ADR Analysts have issued a net profit forecast 2024. The average Legend Biotech Corp - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.94 | -0.89 |
4.63% | 69.73% | |
P/E | negative | |
EV/Sales | 9.90 |
12 Analysts have issued a Legend Biotech Corp - ADR forecast for earnings per share. The average Legend Biotech Corp - ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Legend Biotech Corp - ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Legend Biotech Corp - ADR...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.